Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 3Breast 2Other neoplasm 1Other hematologic neoplasm 1NET 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 874Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Hematologic Neoplasms 462Leukemia, Lymphocytic, Chronic, B-Cell 388Leukemia 328Myelodysplastic Syndromes 324Lymphoma 203Lymphoma, Non-Hodgkin 191Multiple Myeloma 145Leukemia, Myelogenous, Chronic, BCR-ABL Positive 139Recurrence 136Neoplasms 133Leukemia, Myelomonocytic, Chronic 110Burkitt Lymphoma 92Lymphoma, Mantle-Cell 91Lymphoma, Follicular 91Lymphoma, Large B-Cell, Diffuse 88Myeloproliferative Disorders 84Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 81Leukemia, Biphenotypic, Acute 79Lymphoma, B-Cell, Marginal Zone 75Hodgkin Disease 72Lymphoma, B-Cell 64Waldenstrom Macroglobulinemia 54Primary Myelofibrosis 53Leukemia, B-Cell 50Anemia, Refractory, with Excess of Blasts 45Leukemia, Myeloid, Chronic-Phase 40Hematologic Diseases 37Lymphoma, T-Cell 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypersensitivity × Other hematologic neoplasm × 1 year × Clear all
NCT04996875 2026-05-05

APEX

Cogent Biosciences, Inc.

Phase 2 Recruiting
140 enrolled
LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Hypersensitivity, Immune Complex Diseases, Immune System Diseases, Leukemia, Leukemia, Mast-Cell, Leukemia, Myeloid, Mastocytosis, Myeloproliferative Disorders, Neoplasms, Neoplasms by Site, Neoplasms, Connective Tissue, Skin Diseases, Soft Tissue Neoplasms, Urticaria Pigmentosa, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡